COLON-SPECIFIC DELIVERY OF DEXAMETHASONE FROM A GLUCOSIDE PRODRUG IN THE GUINEA-PIG

被引:50
|
作者
TOZER, TN [1 ]
RIGOD, J [1 ]
MCLEOD, AD [1 ]
GUNGON, R [1 ]
HOAG, MK [1 ]
FRIEND, DR [1 ]
机构
[1] SRI INT,DEPT CONTROLLED RELEASE & BIOMED POLYMERS,MENLO PK,CA 94025
关键词
COLON-SPECIFIC DRUG DELIVERY; DEXAMETHASONE; DEXAMETHASONE-BETA-D-GLUCOSIDE; INTESTINAL MICROFLORAL-MEDIATED DRUG HYDROLYSIS; INFLAMMATORY BOWEL DISEASE; PRODRUG; SELECTIVE ADVANTAGE;
D O I
10.1023/A:1015838825437
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Dexamethasone-beta-D-glucoside is a potential prodrug for colonic delivery of the antiinflammatory agent, dexamethasone. The ability of this prodrug to deliver dexamethasone selectively to the colon depends not only on its being slowly absorbed from the alimentary canal, but also on its having chemical and enzymatic stability in the stomach and small intestine. Once reaching the large bowel, it should be quantitatively hydrolyzed to release the active agent. The potential of dexamethasome-beta-D-glucoside for colon-specific delivery of dexamethasone is assessed by determining the rates of its hydrolysis down the alimentary canal of the guinea pig, an animal in which an inflammatory bowel disease model has been developed. The hydrolytic activity is examined in tissues and luminal contents of the stomach, proximal and distal segments of the small intestine, cecum, and colon. For the tissues, the greatest hydrolytic activity is in the proximal small intestine, while the stomach, cecum, and colon have only moderate activity. In contrast, the contents of the cecum and colon show greater activity than the contents of the small intestine and stomach. The luminal contents retained beta-glucosidase activity even after repeated centrifugation and resuspension in a buffer. The activity was unaffected by homogenization. These observations suggest that hydrolytic activity is associated with enzymes located on the surface of luminal cells. The movement and hydrolysis of dexamethasone-beta-D-glucoside down the gastrointestinal tract of the guinea pig are also examined. About 20 to 30% of an oral dose appears to reach the cecum. Here the prodrug is rapidly hydrolyzed to the active drug. From intravenous administration of the prodrug and drug, it is apparent that dexamethasone-beta-D-glucoside is poorly absorbed in the gastrointestinal tract (bioavailability, <1%). There is a ninefold selective advantage for delivery of dexamethasone in cecal tissues in the guinea pig under the conditions of this experiment. Thus, there is a potential for a decrease in the usual dose and a concomitant reduction in the systemic exposure to dexamethasone. Because humans have much less glucosidase activity in the small intestine, even greater site-selective delivery to the cecum and colon is expected.
引用
收藏
页码:445 / 454
页数:10
相关论文
共 50 条
  • [31] EFFECTS OF CISAPRIDE ON ISOLATED GUINEA-PIG COLON
    SYED, MM
    TOKUNO, H
    TOMITA, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 1989, 51 (01): : 47 - 56
  • [32] POTASSIUM SECRETION IN THE GUINEA-PIG DISTAL COLON
    ISHIDA, H
    SUZUKI, Y
    JAPANESE JOURNAL OF PHYSIOLOGY, 1987, 37 (01): : 33 - 48
  • [33] ACTION OF DAUNOMYCIN ON GUINEA-PIG ILEUM AND COLON
    MAZZANTI, L
    BRESCHI, MC
    CREMA, A
    DELTACCA, M
    FARMACO-EDIZIONE PRATICA, 1972, 27 (01): : 49 - &
  • [34] Design and development of SMEDDS for colon-specific drug delivery
    Bansode, Sudhir T.
    Kshirsagar, Sanjay J.
    Madgulkar, Ashwini R.
    Bhalekar, Mangesh R.
    Bandivadekar, Mithun M.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (04) : 611 - 623
  • [35] Coated dosage forms for colon-specific drug delivery
    Leopold, CS
    PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (05): : 197 - 204
  • [36] DRUG GLYCOSIDES IN ORAL COLON-SPECIFIC DRUG DELIVERY
    FRIEND, DR
    TOZER, TN
    JOURNAL OF CONTROLLED RELEASE, 1992, 19 (1-3) : 109 - 120
  • [37] APPROACHES AND OPPORTUNITIES IN COLON-SPECIFIC DRUG-DELIVERY
    RUBINSTEIN, A
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1995, 12 (2-3): : 101 - 149
  • [38] Chitosan dispersed system for colon-specific drug delivery
    Shimono, N
    Takatori, T
    Ueda, M
    Mori, M
    Higashi, Y
    Nakamura, Y
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 245 (1-2) : 45 - 54
  • [39] Use of azo polymers for colon-specific drug delivery
    VandenMooter, G
    Maris, B
    Samyn, C
    Augustijns, P
    Kinget, R
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (12) : 1321 - 1327
  • [40] Compacted Multiparticulate Systems for Colon-Specific Delivery of Ketoprofen
    Rodrigo Gomes de Alencar
    Aline Carlos de Oliveira
    Eliana Martins Lima
    Marcílio Sérgio Soares da Cunha-Filho
    Stephânia Fleury Taveira
    Ricardo Neves Marreto
    AAPS PharmSciTech, 2017, 18 : 2260 - 2268